<!DOCTYPE html>
<!--[if (gt IE 9)|!(IE)]> <!--> <html lang="en" class="no-js has-comments blog-news section-"  itemscope xmlns:og="//opengraphprotocol.org/schema/"> <!--<![endif]-->
<!--[if IE 9]> <html lang="en" class="no-js ie9 lt-ie10 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if IE 8]> <html lang="en" class="no-js ie8 lt-ie10 lt-ie9 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<!--[if (lt IE 8)]> <html lang="en" class="no-js lt-ie10 lt-ie9 lt-ie8 has-comments blog-news section-" xmlns:og="//opengraphprotocol.org/schema/"> <![endif]-->
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var o=n[t]={exports:{}};e[t][0].call(o.exports,function(n){var o=e[t][1][n];return r(o||n)},o,o.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<t.length;o++)r(t[o]);return r}({1:[function(e,n,t){function r(){}function o(e,n,t){return function(){return i(e,[c.now()].concat(u(arguments)),n?null:this,t),n?void 0:this}}var i=e("handle"),a=e(2),u=e(3),f=e("ee").get("tracer"),c=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],d="api-",l=d+"ixn-";a(p,function(e,n){s[n]=o(d+n,!0,"api")}),s.addPageAction=o(d+"addPageAction",!0),s.setCurrentRouteName=o(d+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,o="function"==typeof n;return i(l+"tracer",[c.now(),e,t],r),function(){if(f.emit((o?"":"no-")+"fn-start",[c.now(),r,o],t),o)try{return n.apply(this,arguments)}finally{f.emit("fn-end",[c.now()],t)}}}};a("setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=o(l+n)}),newrelic.noticeError=function(e){"string"==typeof e&&(e=new Error(e)),i("err",[e,c.now()])}},{}],2:[function(e,n,t){function r(e,n){var t=[],r="",i=0;for(r in e)o.call(e,r)&&(t[i]=n(r,e[r]),i+=1);return t}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],3:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,o=t-n||0,i=Array(o<0?0:o);++r<o;)i[r]=e[n+r];return i}n.exports=r},{}],4:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function o(e){function n(e){return e&&e instanceof r?e:e?f(e,u,i):i()}function t(t,r,o,i){if(!d.aborted||i){e&&e(t,r,o);for(var a=n(o),u=m(t),f=u.length,c=0;c<f;c++)u[c].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function l(e,n){v[e]=m(e).concat(n)}function m(e){return v[e]||[]}function w(e){return p[e]=p[e]||o(t)}function g(e,n){c(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var v={},y={},b={on:l,emit:t,get:w,listeners:m,context:n,buffer:g,abort:a,aborted:!1};return b}function i(){return new r}function a(){(s.api||s.feature)&&(d.aborted=!0,s=d.backlog={})}var u="nr@context",f=e("gos"),c=e(2),s={},p={},d=n.exports=o();d.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(o.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return e[n]=r,r}var o=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){o.buffer([e],r),o.emit(e,n,t)}var o=e("ee").get("handle");n.exports=r,r.ee=o},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,i,function(){return o++})}var o=1,i="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=h.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();c(y,function(n,t){e[n]||(e[n]=t)}),f("mark",["onload",a()+h.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function o(){"complete"===d.readyState&&i()}function i(){f("mark",["domContent",a()+h.offset],null,"api")}function a(){return E.exists&&performance.now?Math.round(performance.now()):(u=Math.max((new Date).getTime(),u))-h.offset}var u=(new Date).getTime(),f=e("handle"),c=e(2),s=e("ee"),p=window,d=p.document,l="addEventListener",m="attachEvent",w=p.XMLHttpRequest,g=w&&w.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:w,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var v=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1044.min.js"},b=w&&g&&g[l]&&!/CriOS/.test(navigator.userAgent),h=n.exports={offset:u,now:a,origin:v,features:{},xhrWrappable:b};e(1),d[l]?(d[l]("DOMContentLoaded",i,!1),p[l]("load",r,!1)):(d[m]("onreadystatechange",o),p[m]("onload",r)),f("mark",["firstbyte",u],null,"api");var x=0,E=e(4)},{}]},{},["loader"]);</script>
		<meta name="PT" content="Blogs" />
<meta name="PST" content="Blog Post" />
<meta name="sourceApp" content="blogs" />
<meta itemprop="identifier" name="blogpostid" content="100000003847367"><meta name="author" content="Amie Tsang" />
<meta name="CLMST" content="Amie Tsang" />
<meta name="byl" content="Amie Tsang" />
<meta name="GBLC" content="DealBook">
<meta name="PUV" content="normal" />
<meta property="article:published_time" itemprop="datePublished" content="1439290571" />
<meta name="PUD" content="20150811" />
<meta name="pdate" content="20150811" />
<meta name="ptime" content="20150811065611" />
<meta name="utime" content="20150811105611" />
<meta property="article:modified_time" itemprop="dateModified" content="2015-08-11T10:56:11-04:00" />
<meta name="DISPLAYDATE" content="August 11, 2015" />
<meta name="dat" content="August 11, 2015" />
<meta itemprop="articleSection" property="article:section" content="" />
<meta name="CG" content="" />
<meta name="SCG" content="news" />
<meta name="BN" content="news" />
<meta name="robots" content="noodp">
<meta name="per" content="Buffett, Warren E;Clinton, Hillary Rodham;Gates, Bill;Shareholder Rights and Activism;Warren, Elizabeth">
<meta name="des" content="Bitcoin (Currency);First Amendment (US Constitution);Mergers, Acquisitions and Divestitures;Stocks and Bonds;Taxation">
<meta name="org" content="Berkshire Hathaway Inc;Food and Drug Administration;Google Inc;Mallinckrodt Plc.;Precision Castparts Corporation;Securities and Exchange Commission;Symantec Corporation;Yodlee Inc.">
<meta name="ticker" content="Berkshire Hathaway Inc|BRK.A|NYSE;Google Inc|GOOGL|NASDAQ;Precision Castparts Corporation|PCP|NYSE;Symantec Corporation|SYMC|NASDAQ;Yodlee Inc.|YDLE|NASDAQ" />
<meta property="article:tag" content="Buffett Warren E" />
<meta property="article:tag" content="Clinton Hillary Rodham" />
<meta property="article:tag" content="Gates Bill" />
<meta property="article:tag" content="Shareholder Rights and Activism" />
<meta property="article:tag" content="Warren Elizabeth" />
<meta property="article:tag" content="Bitcoin (Currency)" />
<meta property="article:tag" content="First Amendment (US Constitution)" />
<meta property="article:tag" content="Mergers Acquisitions and Divestitures" />
<meta property="article:tag" content="Stocks and Bonds" />
<meta property="article:tag" content="Taxation" />
<meta property="article:tag" content="Berkshire Hathaway Inc" />
<meta property="article:tag" content="Food and Drug Administration" />
<meta property="article:tag" content="Google Inc" />
<meta property="article:tag" content="Mallinckrodt Plc." />
<meta property="article:tag" content="Precision Castparts Corporation" />
<meta property="article:tag" content="Securities and Exchange Commission" />
<meta property="article:tag" content="Symantec Corporation" />
<meta property="article:tag" content="Yodlee Inc." />
<meta property="article:tag" content="DealBook" />
<meta name="keywords" content="Buffett Warren E,Clinton Hillary Rodham,Gates Bill,Shareholder Rights and Activism,Warren Elizabeth,Bitcoin (Currency),First Amendment (US Constitution),Mergers Acquisitions and Divestitures,Stocks and Bonds,Taxation,Berkshire Hathaway Inc,Food and Drug Administration,Google Inc,Mallinckrodt Plc.,Precision Castparts Corporation,Securities and Exchange Commission,Symantec Corporation,Yodlee Inc.,DealBook" />
<link rel="alternate" type="application/json+oembed" href="https://www.nytimes.com/svc/oembed/json/?url=http%3A%2F%2Fnews.blogs.nytimes.com%2F2015%2F08%2F11%2Fdealbook-stock-buybacks-draw-scrutiny%2F" title="DealBook: Stock Buybacks Draw Scrutiny" />
<meta name="description" content="Warren Buffett Bucks the Trend &#124; Man Charged With Bitcoin Schemes in Court &#124; The F.D.A. and the Free-Speech Fight &#124; Mallinckrodt to Buy Therakos" />
<meta name="hdl" content="DealBook: Stock Buybacks Draw Scrutiny" />
<meta property="og:title" content="DealBook: Stock Buybacks Draw Scrutiny" />
<meta property="og:type" content="article" />
<meta property="og:url" content="//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/" />
<meta property="og:site_name" content="" />
<meta property="og:description" content="Warren Buffett Bucks the Trend &#124; Man Charged With Bitcoin Schemes in Court &#124; The F.D.A. and the Free-Speech Fight &#124; Mallinckrodt to Buy Therakos" />
<meta property="og:image" content="https://static01.nyt.com/images/blogs_v5/../icons/t_logo_2048_black.png"/>
<meta name="thumbnail_150" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta name="twitter:card" value="summary"><meta name="twitter:title" content="DealBook: Stock Buybacks Draw Scrutiny" />
<meta name="twitter:url" content="//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/" />
<meta name="twitter:description" content="Warren Buffett Bucks the Trend &#124; Man Charged With Bitcoin Schemes in Court &#124; The F.D.A. and the Free-Speech Fight &#124; Mallinckrodt to Buy Therakos" />
<meta name="twitter:image" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png"/>
<meta itemprop="thumbnailUrl" content="https://static01.nyt.com/packages/images/icons/t_logo_300_black.png" name="thumbnail" />
<link rel='prev' title='Morning Agenda: S.E.C. Ready to Make a Splash' href='//news.blogs.nytimes.com/2015/08/10/morning-agenda-s-e-c-ready-to-make-a-splash/' />
<link rel='next' title='What We&#8217;re Reading' href='//news.blogs.nytimes.com/2015/08/11/what-were-reading-80/' />
<link rel='canonical' href='//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/' />
<link rel='shortlink' href='//nyti.ms/1N0lK97' />
<link rel='https://github.com/WP-API/WP-API' href='//news.blogs.nytimes.com/json' />
<meta name="adxPage" content="blog.nytimes.com/news/post" />
<link rel="alternate" type="application/rss+xml" title="RSS 2.0" href="//news.blogs.nytimes.com/feed/" />
<meta property="article:collection" content="https://static01.nyt.com/services/json/sectionfronts/index.jsonp" />
<link rel="alternate" href="//mobile.nytimes.com/blogs/news/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/" />
<meta name="dfp-ad-unit-path" content="news" />			<title>DealBook: Stock Buybacks Draw Scrutiny - The New York Times</title>
            <!--[if (gt IE 9)|!(IE)]> <!-->
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles.css" />
<!--<![endif]-->
<!--[if lte IE 9]>
    <link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-ie.css" />
<![endif]-->
<link rel="stylesheet" type="text/css" media="screen" href="https://int.nyt.com/assets/blogs/latest/css/blogs/news.css" />
<link rel="stylesheet" type="text/css" media="print" href="https://int.nyt.com/assets/blogs/latest/css/blogs/styles-print.css" />
<script>
var NYT = NYT || {}, NYTD = NYTD || {};
</script>
                        	<script src="https://int.nyt.com/assets/blogs/latest/js/blogs/layout.js"></script>
	<script type="text/javascript">var googletag=googletag||{};googletag.cmd=googletag.cmd||[],function(){var t=document.createElement("script");t.async=!0,t.type="text/javascript";var e="https:"==document.location.protocol;t.src=(e?"https:":"http:")+"//www.googletagservices.com/tag/js/gpt.js";var o=document.getElementsByTagName("script")[0];if (!/NYT-T=out/.test(document.cookie)) {o.parentNode.insertBefore(t,o)}}();</script>
<script id="magnum-feature-flags" type="application/json">["limitFabrikSave","facebookOauthButton","videoVHSCover","videoVHSShareTools","videoVHSEmbeddedOnly","removeInternationalEdition","piiBlockDFP","indexAsHeaderBidder","caslOpt"]</script>
<script>
var require = {
    baseUrl: 'https://int.nyt.com/assets/',
    waitSeconds: 20,
    paths: {
        'foundation': 'blogs/latest/js/foundation',
        'shared': 'blogs/latest/js/shared',
        'blogs': 'blogs/latest/js/blogs',
        'auth/mtr': 'https://static01.nyt.com/js/mtr',
        'auth/growl': 'https://static01.nyt.com/js/auth/growl/default',
        'vhs': 'https://static01.nyt.com/video/vhs/build/vhs-2.x.min'
    }
};
</script>
<!--[if (gte IE 9)|!(IE)]> <!-->
<script data-main="foundation/main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script>
require.map = { '*': { 'foundation/main': 'foundation/legacy_main' } };
</script>
<script data-main="foundation/legacy_main" src="https://int.nyt.com/assets/blogs/latest/js/foundation/lib/framework.js"></script>
<![endif]-->
<script>
require(['foundation/main'], function () {
    require(['auth/mtr']);
});
</script>
<!--esi
<script id="user-info-data" type="application/json">
<esi:include src="/svc/web-products/userinfo-v3.json" />
</script>
-->
    	</head><body class="single single-post postid-2990 blog-universal nyt-blog-news full-width-headline" id="" data-env="production" data-region="ewr1">
	<div id="shell" class="shell">
			<header id="masthead" class="masthead masthead-theme-standard" role="banner">
    <div class="container">
        <div class="quick-navigation button-group">
            <button class="button sections-button"><i class="icon sprite-icon"></i><span class="button-text">Sections</span></button>
            <button class="button home-button" data-href="https://www.nytimes.com/" title="Go to the home page to see the latest top stories."><i class="icon sprite-icon"></i>
                <span class="button-text">Home</span>
            </button>
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <a class="button skip-button skip-to-content visually-hidden focusable" href="#main">Skip to content</a>
                                </div><!-- close button-group -->
        <div class="branding">
            <h2 class="branding-heading">
                <a id="branding-heading-link" href="https://www.nytimes.com/">
                    <span class="visually-hidden">The New York Times</span>
                </a>
            </h2>
            <script>window.magnum.writeLogo('small', 'https://int.nyt.com/assets/blogs/latest/images/foundation/logos/', '', 'masthead-theme-standard', 'standard', 'branding-heading-link', 'blogs');</script>
        </div><!-- close branding -->
        <div class="story-meta">
    <h6 class="kicker">
        <span class="kicker-label">
			            <a href="//news.blogs.nytimes.com">
                News            </a>
			        </span>

                <span class="pipe">|</span>
        DealBook: Stock Buybacks Draw Scrutiny        
    </h6>
</div><!-- close story-meta -->


        <div class="user-tools">
            <div id="Bar1" class="ad bar1-ad nocontent robots-nocontent"></div>
            <div id="sharetools-masthead" class="sharetools theme-classic"
	 data-shares="email,facebook,twitter,show-all|More"
	 data-url="//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/"
	 data-title="DealBook: Stock Buybacks Draw Scrutiny"
	 data-description="&lt;span class=&quot;excerpt-inner&quot;&gt; Warren Buffett Bucks the Trend | Man Charged With Bitcoin Schemes in Court | The F.D.A. and the Free-Speech Fight | Mallinckrodt to Buy Therakos&lt;/span&gt;&lt;a href=&quot;//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
	data-publish-date="August 11, 2015 6:56 am">
<div class="ad sharetools-inline-article-ad hidden"></div>
</div><!-- close shareTools -->
            <button class="button search-button"><i class="icon sprite-icon"></i><span class="button-text">Search</span></button>
            <div class="user-tools-button-group button-group">
                <button class="button subscribe-button hidden" data-href="https://www.nytimes.com/subscriptions/Multiproduct/lp3004.html?campaignId=4XUYF">Subscribe Now</button>
                <button class="button login-button login-modal-trigger hidden">Log In</button>
                <button class="button comments-button  button-masthead" data-skip-to-para-id="">
</button>
                                <button class="button notifications-button hidden"><i class="icon sprite-icon"></i><span class="button-text">0</span></button>
                <button class="button user-settings-button"><i class="icon sprite-icon"></i><span class="button-text">Settings</span></button>
            </div><!-- close user-tools-button-group -->
        </div><!-- close user-tools -->
    </div><!-- close container -->
    <div class="search-flyout-panel flyout-panel">
    <button class="button close-button" type="button"><i class="icon"></i><span class="visually-hidden">Close search</span></button>
    <nav class="search-form-control form-control layout-horizontal">
    <h2 class="visually-hidden">Site Search Navigation</h2>
    <form class="search-form" role="search">
        <div class="control">
            <div class="label-container visually-hidden">
                                <label for="search-input">Search NYTimes.com</label>
                            </div>
            <div class="field-container">
                                <input id="search-input" name="search-input" type="text" class="search-input text" autocomplete="off" placeholder="Search NYTimes.com" />
                
                <button type="button" class="button clear-button" tabindex="-1" aria-describedby="clear-search-input"><i class="icon"></i><span id="clear-search-input" class="visually-hidden">Clear this text input</span></button>
                <div class="auto-suggest" style="display: none;">
                    <ol></ol>
                </div>
                <button class="button submit-button" type="submit">Go</button>
            </div>
        </div><!-- close control -->
    </form>
</nav>


</div><!-- close flyout-panel -->
    <div id="notification-modals" class="notification-modals"></div>
</header>
					<nav id="ribbon" class="ribbon ribbon-start nocontent robots-nocontent" aria-hidden="true">
    <div class="nocontent robots-nocontent">
        <ol class="ribbon-menu">
            <li class="collection ribbon-loader">
                <div class="loader "><span class="visually-hidden">Loading...</span></div>
            </li>
        </ol>
        <div class="ribbon-navigation-container">
            <nav class="ribbon-navigation next">
                <span class="visually-hidden">See next articles</span>
                <div class="arrow arrow-right">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
            <nav class="ribbon-navigation previous">
                <span class="visually-hidden">See previous articles</span>
                <div class="arrow arrow-left">
                    <div class="arrow-conceal"></div>
                </div>
            </nav>
        </div>
    </div><!-- close nocontent -->
</nav>
						<nav id="navigation" class="navigation">
    <h2 class="visually-hidden">Site Navigation</h2>
</nav><!-- close navigation -->

<nav id="mobile-navigation" class="mobile-navigation hidden">
    <h2 class="visually-hidden">Site Mobile Navigation</h2>
</nav><!-- close mobile-navigation -->

    <div id="navigation-edge" class="navigation-edge"></div>
				<main id="main" class="main" role="main">
				<div id="TopAd" class="ad top-ad"></div>
				<div id="mobilebanner" class="ad mobilebanner"></div>
								<div id="story" class="story theme-main">
		<div id="news" class="spanAC blog">
				<div class="postHeader story-header">
	<div class="story-meta">
						<h1 class="entry-title story-heading">DealBook: Stock Buybacks Draw Scrutiny</h1>
		<div class="story-meta-footer">
			<address class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
				By Amie Tsang			</address>
			<!-- date published --><time class="dateline " datetime="2015-08-11T10:56:11+00:00" itemprop="datePublished">August 11, 2015</time>
			<!-- date updated --><span class="visually-hidden updated">August 11, 2015</span>			<div class="inside-story"></div><!-- Although this is empty, it is required for layout parity with NYT5 -->
		</div>
	</div>
</div>
<div class="a-column" id="a-col">
	<div id="content" class="hfeed">
			<article class="post-2990 post type-post status-publish hentry category-dealbook tag-berkshire-hathaway-inc tag-bitcoin-currency tag-buffett-warren-e tag-clinton-hillary-rodham tag-first-amendment-us-constitution tag-food-and-drug-administration tag-gates-bill tag-google-inc tag-mallinckrodt-plc tag-mergers-acquisitions-and-divestitures tag-precision-castparts-corporation tag-securities-and-exchange-commission tag-shareholder-rights-and-activism tag-stocks-and-bonds tag-symantec-corporation tag-taxation tag-warren-elizabeth tag-yodlee-inc per-buffett-warren-e per-clinton-hillary-rodham per-gates-bill per-shareholder-rights-and-activism per-warren-elizabeth des-bitcoin-currency des-first-amendment-us-constitution des-mergers-acquisitions-and-divestitures des-stocks-and-bonds des-taxation org-berkshire-hathaway-inc org-food-and-drug-administration org-google-inc org-mallinckrodt-plc org-precision-castparts-corporation org-securities-and-exchange-commission org-symantec-corporation org-yodlee-inc" id="post-2990">
                        <div class="visually-hidden">
                <span itemprop="headline" class="entry-title">DealBook: Stock Buybacks Draw Scrutiny</span>
                <span class="byline author vcard" itemprop="author creator" itemtype="//schema.org/Person">
                    By Amie Tsang                </span>
                <!-- date published --><time class="dateline " datetime="2015-08-11T10:56:11+00:00" itemprop="datePublished">August 11, 2015 6:56 am</time>
			<!-- date updated --><span class="visually-hidden updated">August 11, 2015 6:56 am</span>            </div>
			<div class="entry-content">
			<div id="sharetools-story" class="sharetools theme-classic sharetools-story" data-shares="email|Email,facebook|Share,twitter|Tweet,save|Save,show-all|More,ad" data-url="//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/" data-title="DealBook: Stock Buybacks Draw Scrutiny" data-description=" Warren Buffett Bucks the Trend | Man Charged With Bitcoin Schemes in Court | The F.D.A. and the Free-Speech Fight | Mallinckrodt to Buy Therakos">
				<div class="ad sharetools-inline-article-ad"></div>
				<div id="MiddleLeft" class="ad middle-left-ad nocontent robots-nocontent"></div>
				</div><div class="round-up">
<div class="ru-top-story">
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>STOCK BUYBACKS DRAW SCRUTINY</strong> <span class="divider"> | </span></span> Debate over buybacks has grown and corporate America is worried, <a href="//www.nytimes.com/2015/08/11/business/stock-buybacks-draw-scrutiny-from-politicians.html?ref=dealbook">Andrew Ross Sorkin writes in the DealBook column</a>. The buyback bug, which has bitten big companies from Apple to General Electric, has led to a <b>backlash from investors and government officials</b>. They doubt that using profits like that is a productive way to deploy capital compared with reinvesting in businesses and jobs. </p>
<p class="story-body-text" itemprop="articleBody"> Senator Elizabeth Warren and Senator Tammy Baldwin have made explosive claims that buybacks might be a <b>form of market manipulation</b>. Both senators have urged the Securities and Exchange Commission to investigate the practice. âThese buybacks were treated as stock manipulation for decades because that is exactly what they are,â Ms. Warren said.</p>
<p class="story-body-text" itemprop="articleBody">  Hillary Rodham Clinton also got the attention of industry in a speech when she said, âInvestors and regulators alike <b>need more information about these transactions</b>. Capital markets work best when information is promptly and widely available to all.â She pointed out that in places like Britain and Hong Kong, stock buybacks have to be disclosed in one day, whereas in the United States, companies can go an entire quarter without disclosing. </p>
<p class="story-body-text" itemprop="articleBody"> Mr. Sorkin notes that if the disclosure rule were changed, it would probably  <b>make it tougher and more expensive</b>  for American companies to buy back shares. </p>
<p class="story-body-text" itemprop="articleBody"> The surge in buybacks followed a provision that gave companies so-called safe harbor against charges of manipulation if they bought their stock in the open market under certain circumstances. Buybacks are considered shareholder friendly, and tax efficient because there is <b>no tax to be immediately paid</b>, unlike a dividend.</p>
<p class="story-body-text" itemprop="articleBody"> But they also benefit executives seeking to lift their pay. Buybacks allow companies to issue more stock to executives <b>without diluting other shareholders</b>. </p>
<p class="story-body-text" itemprop="articleBody"> Another point of contention is that buybacks <b>increase earnings per share</b>, a metric that some compensation committees use to determine the pay of their executives. On top of that, it also increases stock price in the short term regardless of operational success, potentially letting executives cash out of some of their shares at artificially high prices. </p>
<p class="story-body-text" itemprop="articleBody"> Although buybacks can have their drawbacks, it is hard to tell a company how it can or cannot spend its money, Mr. Sorkin writes. âUltimately, the pressure for companies to invest in their operations and new jobs is only going to come when <b>managements see a real business opportunity</b> â and shareholders demand it.â</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>MAN CHARGED WITH BITCOIN SCHEME IN COURT</strong> <span class="divider"> | </span></span> Anthony Murgio, a Florida man, was charged with running an <b>illegal bitcoin money exchange company</b> and is thought to have information about the hacking attack last summer against JPMorgan Chase. He said nothing when he appeared in court, letting his lawyer do the talking, <a href="//www.nytimes.com/2015/08/11/business/man-charged-in-bitcoin-scheme-appears-in-new-york-court.html?ref=dealbook">Matthew Goldstein reports in DealBook</a>. </p>
<p class="story-body-text" itemprop="articleBody"> Mr. Murgio <b>remains free on $100,000 bail</b>, which was posted a week ago. He was arrested on July 21 in Tampa and spent a few nights in the Pinellas County jail while he and his family secured the money. </p>
<p class="story-body-text" itemprop="articleBody"> Federal authorities contend that his company, Coin.mx, allowed online criminals to illegally exchange bitcoin for cash as part of a money-laundering scheme. Mr. Murgio <b>could be sentenced to up to 20 years</b> in prison if convicted. His partner in the company, Yuri Lebedev, faces a similar charge and is free on $25,000 bail. </p>
<p class="story-body-text" itemprop="articleBody"> Neither has been charged with any wrongdoing in connection with the hacking at JPMorgan. But federal authorities want to know what information Mr. Murgio may have about the attack, as his name surfaced <b>early in the inquiry by the Federal Bureau of Investigation</b>, people briefed on the investigation have said.</p>
<p class="story-body-text" itemprop="articleBody"> One of his friends, Joshua Aaron, also came to the attention of the F.B.I. He has been charged with operating a series of schemes to pump up the prices of otherwise worthless stocks. Authorities have declined to discuss what led them to think Mr. Murgio and Mr. Aaron might have information about the JPMorgan attack. People briefed on the matter said that Mr. Aaron might have used information gathered in the breach, like <b>purloined email addresses and customer home addresses</b>, to put together a list of potential victims to pitch stocks. </p>
<p class="story-body-text" itemprop="articleBody"> They both <b>visited Russia</b> in the last few years. The authorities suspect the actual hackers may be in Russia or another European country.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>WARREN BUFFETT BUCKS THE TREND</strong> <span class="divider"> | </span></span> When Berkshire Hathaway first invested in Precision Castparts three years ago, Warren Buffett had hardly heard of the metal parts manufacturer. Now he has bought the company in his biggest takeover ever. The <b>$32 billion purchase</b> will help Berkshire Hathaway move further into the industrial sector, <a href="//www.nytimes.com/2015/08/11/business/dealbook/berkshire-hathaway-to-buy-precision-castparts-for-37-2-billion.html?ref=international">Michael J. de la Merced and Chad Bray write in DealBook</a>. It is also betting that Precision Castparts, whose turbine airfoils and valves are used by companies like Boeing and Airbus, will benefit from growing numbers in airline travel.</p>
<p class="story-body-text" itemprop="articleBody"> Berkshire Hathaway is generally expected to strike huge deals â the company generates an enormous amount of cash and is sitting on <b>nearly $67 billion as of June 30</b>. </p>
<p class="story-body-text" itemprop="articleBody"> Although the acquisition fits Mr. Buffettâs mold, it also  <b>coincides with cyclical highs</b>  in plane orders, stock valuations, and mergers and acquisitions, <a href="//www.nytimes.com/2015/08/11/business/warren-buffett-bucks-trends-with-precision-castparts-acquisition.html">Antony Currie writes in Breakingviews</a>. </p>
<p class="story-body-text" itemprop="articleBody"> Mr. Currie notes that Precision Castpartsâ <b>shares have tumbled 40 percent</b> since their peak in June of last year â just the sort of opportunity Mr. Buffett is known to relish.</p>
<p class="story-body-text" itemprop="articleBody"> Although aircraft orders have increased, it is not clear that this pace of growth can be sustained, and a minority of analysts published by Reuters have the equivalent of a buy rating on the stock. This makes the deal a  <b>rather contrarian investment</b>, Mr. Currie notes.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>THE F.D.A. AND THE FREE-SPEECH FIGHT</strong> <span class="divider"> | </span></span> The Food and Drug Administration takes the position that when it approves a drug for a particular treatment, the manufacturer of that drug cannot promote it for other uses even if those statements are true. That policy has been called into question in a decision by Judge Paul A. Engelmayer, who found that the First Amendment protects drug companies that want to make truthful statements about their drugs, even if it is for an unapproved use, <a href="//www.nytimes.com/2015/08/11/business/dealbook/fdas-off-label-drug-policy-leads-to-free-speech-fight.html?ref=dealbook">Peter J. Henning writes in the White Collar Watch column</a>. This sets up a likely appeal to determine just how far the government can go <b>to punish speech that is truthful</b>.</p>
<p class="story-body-text" itemprop="articleBody"> Amarin Pharma, a small drug manufacturer, challenged the F.D.A. when it wanted to promote the off-label use of its cardiovascular health drug, Vascepa, for patients with a different condition. An F.D.A.-approved study showed that the use of the drug was effective, but the <b>agency denied approval</b> for use by those patients.</p>
<p class="story-body-text" itemprop="articleBody"> The company and four doctors sued the F.D.A. after it threatened to bring civil charges against them if they used the study to help sell off-label use of Vascepa. They claim that the agencyâs rule <b>violates their First Amendment right to free speech</b>, asking the district court to block enforcement. Judge Engelmayer sided with the company. </p>
<p class="story-body-text" itemprop="articleBody"> Mr. Henning notes that the decision is ânot a license for pharmaceutical manufacturers to start bombarding doctors with promotional materials for new uses of their products. They <b>need to be careful to stay well within the requirement</b> that any statements be truthful and not misleading, lest they cross the line into fraud. As long as they do, then the type of blockbuster settlements for off-label promotions may be a thing of the past.â</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>ON THE AGENDA</strong> <span class="divider"> | </span></span> The Bureau of Labor Statistics releases data on  <b>productivity and labor costs</b> at 8:30 a.m.  <b>Symantec</b> reports quarterly earnings after the bell and will discuss the results at 5 p.m. </p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>MALLINCKRODT TO ACQUIRE THERAKOS</strong> <span class="divider"> | </span></span> Mallinckrodt Pharmaceuticals, a maker of drugs and medical devices, said that it had agreed to buy Therakos from the American private equity firm Gores Group for about $1.33 billion, <a href="//www.nytimes.com/2015/08/11/business/dealbook/mallinckrodt-to-acquire-therakos-for-1-33-billion.html?ref=international">Chad Bray reports in DealBook</a>.</p>
<p class="story-body-text" itemprop="articleBody">The purchase of Therakos, which makes immunotherapy treatment devices, is expected to  <b>broaden Mallinckrodtâs specialty segment</b> and to expand its business in hospitals. This would give it a larger presence in the market for pain management and critical-care respiratory therapies in neonatal intensive care units.</p>
<p class="story-body-text" itemprop="articleBody">It is also the latest in a  <b>deal-making binge</b>  by Mallinckrodt, which last year acquired  Cadence, a biopharmaceutical company in San Diego, for $1.3 billion and bought Questcor Pharmaceuticals for $5.6 billion. It also acquired Ikaria, a maker of treatments for critically ill infants, for $2.3 billion in March.</p>
<p class="story-body-text" itemprop="articleBody">Mallinckrodt is under pressure because the growth of its biggest product, HP Acthar Gel, seems to be slowing, only a year after Mallinckrodt obtained the ultraexpensive, immune-modulating drug. Its shares fell last week after the company  <b>lowered sales expectations</b> for Acthar in announcing quarterly earnings.</p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong></strong> <span class="divider"> | </span></span> <em>Contact <a href="mailto:amie.tsang@nytimes.com">amie.tsang@nytimes.com</a></em></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//dealbook.blogs.nytimes.com/category/mergers-acquisitions/">Mergers &#038; Acquisitions &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Terex Corporation and Konecranes of Finland Agree to Merge</strong> <span class="divider"> | </span></span> The combined company would be a big supplier of cranes and heavy equipment, with estimated revenue of about $10 billion a year.<br /><span class="kicker"><a href="//www.nytimes.com/2015/08/12/business/dealbook/terex-konecranes-merger.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Yodlee, a Hub for Financial Apps, Sells Itself to Envestnet</strong> <span class="divider"> | </span></span> Yodlee, a public company for less than a year, will give Envestnet, a software provider, a new tool to market to financial advisers.<br /><span class="kicker"><a href="//www.nytimes.com/2015/08/11/business/dealbook/yodlee-a-hub-for-financial-apps-sells-itself-to-envestnet.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Just Retirement to Buy Rival in $1 Billion Deal</strong> <span class="divider"> | </span></span> Britainâs Just Retirement has agreed to buy its rival Partnership Assurance for 669 million pounds, or $1 billion, in shares, hoping greater scale and a stronger capital position will help it cope with changes that have rocked its industry.<br /><span class="kicker"><a href="//www.nytimes.com/reuters/2015/08/11/business/11reuters-just-retirement-partnership-m-a.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Symantec Agrees to Sell Data Storage Unit to Carlyle</strong> <span class="divider"> | </span></span> The software security company Symantec has agreed to sell its data storage business Veritas to the private equity firm Carlyle Group, according to a person familiar with the matter.<br /><span class="kicker"><a href="//www.nytimes.com/reuters/2015/08/11/business/11reuters-symantec-divestiture-carlyle-group.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Baxalta Chief Denounces Shireâs âLowballâ Offer</strong> <span class="divider"> | </span></span> Baxalta has doubled down on its opposition to a $30 billion hostile takeover approach from Shire, describing the opening offer as a âlowball valuation.â<br /><span class="kicker"><a href="//www.ft.com/cms/s/0/029f4680-3f99-11e5-b98b-87c7270955cf.html#ixzz3iUmt0xtn"> THE FINANCIAL TIMES </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/b/banks_and_banking/index.html">INVESTMENT BANKING &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Warren Raises Fears Over Symphony</strong> <span class="divider"> | </span></span> Senator Elizabeth Warren has waded into controversy surrounding Symphony, a messaging service backed by a host of Wall Street banks, by warning six financial regulators that the tool could be used to circumvent compliance controls.<br /><span class="kicker"><a href="//www.ft.com/fastft/373871/elizabeth-warren-symphony"> THE FINANCIAL TIMES </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/h/hedge_funds/index.html">HEDGE FUNDS &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>More Companies Deal With Multiple Activists</strong> <span class="divider"> | </span></span> Activist investors, who take positions and agitate for financial or strategic changes, are increasingly showing up in the same stocks, often with different agendas.<br /><span class="kicker"><a href="//www.wsj.com/articles/more-companies-deal-with-multiple-activists-1439248120?mod=pls_whats_news_us_business_f"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/v/venture_capital/index.html">VENTURE CAPITAL &#187;</a></h6>
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Start-Ups Vie to Build an Uber for Health Care</strong> <span class="divider"> | </span></span> Health care ventures are attracting investment and partnerships with hospital systems, which increasingly see in-home care as a way to reduce unnecessary emergency room visits and readmissions.<br /><span class="kicker"><a href="//www.wsj.com/articles/startups-vie-to-build-an-uber-for-health-care-1439265847?mod=pls_whats_news_us_business_f"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Bill Gates Joins $120 Million Fundraising for Editas Medicine Gene Start-Up</strong> <span class="divider"> | </span></span> Bill Gates and the venture capital arm of Google have participated in a $120 million fundraising for Editas Medicine, a biotech group focused on a nascent area of medical science that seeks to use âgene editingâ to tackle serious diseases.<br /><span class="kicker"><a href="//www.ft.com/cms/s/0/bd0f94ae-3f79-11e5-b98b-87c7270955cf.html#ixzz3iUnM6R5z"> THE FINANCIAL TIMES </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="Google to Reorganize in Move to Keep Its Lead as an Innovator" src="https://static01.nyt.com/images/2015/08/11/business/11google-web3/11google-web3-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Google to Reorganize in Move to Keep Its Lead as an Innovator</strong> <span class="divider"> | </span></span> Under the new name, Alphabet, the company is signaling that it has essentially become a collection of disparate businesses.<br /><span class="kicker"><a href="//www.nytimes.com/2015/08/11/technology/google-alphabet-restructuring.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="round-up">
<div class="ru-top-story">
<h6 class="kicker"><a href="//topics.nytimes.com/top/reference/timestopics/subjects/c/credit_crisis/financial_regulatory_reform/index.html">LEGAL/REGULATORY &#187;</a></h6>
<div class="ru-story">
<div class="w75 right"><img width="75" height="75" border="0" alt="China Devalues Its Currency as Worries Rise About Economic Slowdown" src="https://static01.nyt.com/images/2015/08/12/business/11yuan/11yuan-square320.jpg"/></div>
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>China Devalues Its Currency as Worries Rise About Economic Slowdown</strong> <span class="divider"> | </span></span> The move appeared to be a response to signs that the economy was slowing too fast for comfort and could raise tensions with trading partners like the United States.<br /><span class="kicker"><a href="//www.nytimes.com/2015/08/11/business/international/china-lowers-value-of-its-currency-as-economic-slowdown-raises-concerns.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>Guggenheim Partners Pays $20 Million to Settle S.E.C. Charges</strong> <span class="divider"> | </span></span> The settlement covers a charge brought by the Securities and Exchange Commission that the firm failed to disclose a $50 million loan from a client to an executive.<br /><span class="kicker"><a href="//www.nytimes.com/2015/08/11/business/guggenheim-partners-pays-dollar20-million-to-settle-sec-charges.html">NYT &#187;</a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>StanChart Bolsters Financial Crime Team </strong> <span class="divider"> | </span></span> Standard Chartered is under investigation by United States regulators for flouting sanctions laws following a fine in 2012 and has announced new appointments to its financial crime team. <br /><span class="kicker"><a href="//www.ft.com/cms/s/0/10ae1476-3f6d-11e5-b98b-87c7270955cf.html#ixzz3iUlagHWf"> THE FINANCIAL TIMES </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story -->
<div class="ru-story">
<p class="story-body-text" itemprop="articleBody"><span class="title"><strong>The Unintended Consequences of the C.E.O. Pay Ratio Rule</strong> <span class="divider"> | </span></span> If the rule requiring companies to reveal their chief executive pay ratio is implemented, a high median compensation could attract activist investors who believe the company is failing to adequately control costs, Ronald Barusch argues in the Dealpolitik column. <br /><span class="kicker"><a href="//blogs.wsj.com/moneybeat/2015/08/10/dealpolitik-unintended-consequences-of-ceo-pay-ratio-rule/"> THE WALL STREET JOURNAL </a></span></p>
</div>
<p class="story-body-text" itemprop="articleBody"><!-- end .ru-story --></div>
</div>
<div class="newsletter-signup">
<p class="story-body-text" itemprop="articleBody"><a href="//dealbook.nytimes.com/dealbook-e-mail/">Sign up for the DealBook Newsletter</a>, delivered every morning and afternoon.</p>
</div>
<p class="story-body-text" itemprop="articleBody"></p>
</div>
			<footer class="entry-footer">
				
				<div id="sharetools-post-footer" class="sharetools theme-classic"
					data-shares="show-all|Share"
					data-url="//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/"
					data-title="DealBook: Stock Buybacks Draw Scrutiny"
					data-description="&lt;span class=&quot;excerpt-inner&quot;&gt; Warren Buffett Bucks the Trend | Man Charged With Bitcoin Schemes in Court | The F.D.A. and the Free-Speech Fight | Mallinckrodt to Buy Therakos&lt;/span&gt;&lt;a href=&quot;//news.blogs.nytimes.com/2015/08/11/dealbook-stock-buybacks-draw-scrutiny/&quot; class=&quot;more-link&quot;&gt;Read&nbsp;more...&lt;/a&gt;"
					>
					<div class="ad sharetools-inline-article-ad hidden"></div>
				</div>
				<div class="footer-tags">
									</div>
			</footer>
		</article>
		<section id="whats-next" class="whats-next nocontent robots-nocontent">
    <h2 class="visually-hidden">What's Next</h2>
    <div class="nocontent robots-nocontent">
        <div class="loader-container">
            <div class="loader loader-t-logo-32x32-ecedeb-ffffff"><span class="visually-hidden">Loading...</span></div>
        </div>
    </div><!-- close nocontent -->
</section>

		</div> <!-- end content -->
</div><!-- end .a-column -->
<div class="cColumn nocontent robots-nocontent">
	<aside>
			<div class="module ad" id="MiddleRight"></div>
        	</aside>
</div>		<div class="clear"></div>
	</div><!-- end blog wrap -->
	<div class="hideContent"></div>

	
<!-- Google Analytics start -->
<script type="text/javascript">
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){ (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o), m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;if (!/NYT-T=out/.test(document.cookie)) {m.parentNode.insertBefore(a,m)} })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
ga('create', 'UA-4406282-154',  { 'alwaysSendReferrer': true } );
ga('send', 'pageview');
</script>
<!-- Google Analytics end -->
		<div id="mobilebanner2" class="ad mobilebanner2"></div>
		<div class="accessibility-ad-header visually-hidden">
    <p>Advertisement</p>
</div>
<div id="SponLink" class="text-ad bottom-left-ad nocontent robots-nocontent"></div>

		<div id="Top5" class="ad top5-ad hidden nocontent robots-nocontent"></div>

					</div>
			<div class="search-overlay"></div>
		</main><!-- close main -->
						<footer id="page-footer" class="page-footer" role="contentinfo">
    <nav>
         <ul>
             <li>
                <a href="https://www.nytco.com" itemprop="copyrightNotice">
                    &copy; <span itemprop="copyrightYear">2017</span>
					<span itemprop="copyrightHolder provider sourceOrganization" itemscope
						itemtype="//schema.org/Organization"
						itemid="//www.nytimes.com">
						<span itemprop="name"> The New York Times Company</span>
						<meta itemprop="tickerSymbol" content="NYSE NYT"/>
					</span>
                </a>
            </li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/infoservdirectory.html">Contact Us</a></li>
            <li><a href="//www.nytco.com/careers/">Work With Us</a></li>
            <li><a href="//nytmediakit.com/">Advertise</a></li>
            <li><a href="https://www.nytimes.com/content/help/rights/privacy/policy/privacy-policy.html#pp">Your Ad Choices</a></li>
            <li><a href="https://www.nytimes.com/privacy">Privacy</a></li>
            <li><a href="https://www.nytimes.com/ref/membercenter/help/agree.html" itemprop="usageTerms">Terms of Service</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/content/help/rights/sale/terms-of-sale.html">Terms of Sale</a></li>
         </ul>
    </nav>
    <nav class="last-nav">
        <ul>
            <li><a href="//spiderbites.nytimes.com">Site Map</a></li>
            <li><a href="https://www.nytimes.com/membercenter/sitehelp.html">Help</a></li>
            <li><a href="https://myaccount.nytimes.com/membercenter/feedback.html">Site Feedback</a></li>
            <li class="last-item"><a href="https://www.nytimes.com/subscriptions/Multiproduct/lp5558.html?campaignId=37WXW">Subscriptions</a></li>
        </ul>
    </nav>
</footer>		</div><!-- close shell -->
	<script>
require(['foundation/main'], function () {
    require(['blogs/main']);
    require(['jquery/nyt', 'foundation/views/page-manager'], function ($, pageManager) {
        if (window.location.search.indexOf('disable_tagx') > 0) {
            return;
        }
        $(document).ready(function () {
            require(['https://a1.nyt.com/analytics/json-kidd.min.js'], function () {
                pageManager.trackingFireEventQueue();
            });
        });
    });
});
</script>

	<div id="Inv1" class="ad inv1-ad hidden"></div>
<div id="Inv2" class="ad inv2-ad hidden"></div>
<div id="Inv3" class="ad inv3-ad hidden"></div>
<div id="ab1" class="ad ab1-ad hidden"></div>
<div id="ab2" class="ad ab2-ad hidden"></div>
<div id="ab3" class="ad ab3-ad hidden"></div>
<div id="prop1" class="ad prop1-ad hidden"></div>
<div id="prop2" class="ad prop2-ad hidden"></div>
<div id="Anchor" class="ad anchor-ad hidden"></div>
<div id="ADX_CLIENTSIDE" class="ad adx-clientside-ad hidden"></div>
		<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"b5bcf2eba4","applicationID":"5164608","transactionName":"YwFXZhRYVhAEVUZcX1pLYEAPFlkTFRtQWV9TFxtCDkk=","queueTime":0,"applicationTime":50,"ttGuid":"","agentToken":"","userAttributes":"","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
